CRISPR biosensing with lateral flow assays for point of care Diagnostics: Overcoming commercial development challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CRISPR biosensing with lateral flow assays for point of care Diagnostics: Overcoming commercial development challenges

Published:2025-08 Issue: Volume:189 Page:118275
ISSN:0165-9936
Container-title:TrAC Trends in Analytical Chemistry
language:en
Short-container-title:TrAC Trends in Analytical Chemistry

Author:

Hall Tim,Gulati Sneha,Sang Rui,Jia Zhengyang,Mckinnirey Flyn,Vesey Graham,Goldys Ewa,Deng Fei^ORCID

Publisher

Elsevier BV

Reference92 articles.

1. Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests;Kahn;BMC Infect. Dis.,2021

2. Clinical evaluation of rapid point-of-care antigen tests for diagnosis of SARS-CoV-2 infection;Koeleman;Eur. J. Clin. Microbiol. Infect. Dis.,2021

3. Lateral flow assays in infectious disease diagnosis;Boehringer;Clin. Chem.,2021

4. A CRISPR-Based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection;Kaminski;Nat. Biomed. Eng.,2020

5. A CRISPR/Cas12a based universal lateral flow biosensor for the sensitive and specific detection of African swine-fever viruses in whole blood;Wu;Biosensors,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP